CV Therapeutics Ranexa Pre-Launch Steps Will Ramp Up After Cmte. Review

CV Therapeutics expects to begin hiring Ranexa sales reps following the chronic angina therapy's review by FDA's Cardiovascular & Renal Drugs Advisory Committee in September, the company said July 17